Cure My Disease

Don't miss your cure!

 Log in / Sign up

New blood test could spot leukemia return months earlier

NCT ID NCT07500441

Recruiting now Knowledge-focused Sponsor: Peking University People's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new, highly sensitive blood test (digital PCR) to find tiny amounts of leukemia cells that remain after a stem cell transplant in people with acute myeloid leukemia (AML). The goal is to see if this test can predict a relapse earlier than current methods. About 100 participants will have their blood checked at several time points over the first year after transplant. The study does not provide a treatment, but aims to improve how doctors monitor for disease return.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia Neoplasm, Residual

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYELOID LEUKEMIA (AML)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Peking University People's Hospital

    RECRUITING

    Beijing, Beijing Municipality, China